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ABSTRACT
A vector system is presented that allows generation
of E. coli co-expression clones by a standardized,
robust cloning procedure. The number of
co-expressed proteins is not limited. Five ‘pQLink’
vectors for expression of His-tag and GST-tag
fusion proteins as well as untagged proteins and
for cloning by restriction enzymes or Gateway
cloning were generated. The vectors allow
proteins to be expressed individually; to achieve
co-expression, two pQLink plasmids are
combined by ligation-independent cloning. pQLink
co-expression plasmids can accept an unrestricted
number of genes. As an example, the co-expression
of a heterotetrameric human transport protein
particle (TRAPP) complex from a single plasmid,
its isolation and analysis of its stoichiometry
are shown. pQLink clones can be used directly for
pull-down experiments if the proteins are expressed
with different tags. We demonstrate pull-down
experiments of human valosin-containing protein
(VCP) with fragments of the autocrine motility factor
receptor (AMFR). The cloning method avoids PCR or
gel isolation of restriction fragments, and a single
resistance marker and origin of replication are used,
allowing over-expression of rare tRNAs from a
second plasmid. It is expected that applications
are not restricted to bacteria, but could include
co-expression in other hosts such as Bacluovirus/
insect cells.
INTRODUCTION
Co-expression of subunits is an important technique
in the study of protein complexes. Proteins that form
tight complexes with partners may not be soluble when
over-expressed alone (1). Proteins that form stable
homodimers may only form heterodimers upon
co-expression, but not by mixing the purified complex
partners (2,3). The Protein Structure Factory has estab-
lished high throughput protein expression procedures for
human proteins in E. coli (4,5). To achieve co-expression
in a systematic way we have created a new vector system
described here.
Co-expression is often achieved with two or more
plasmids, each carrying the gene of one subunit and
a different selection marker (6). The plasmids should
also have different compatible replicons, although
co-expression with plasmids that have the same replicon
has been demonstrated (7). Instead of multiple vectors,
several genes can be inserted into the same vector. This
requires a vector with more than one multiple cloning
site and the use of different sets of restriction enzymes for
each cloning step (8). Genes are transcribed either from
individual promoters or from a single promoter, leading
to a long polycistronic mRNA. Polycistronic expression
has been reported to lead to lower expression of the more
downstream encoded protein, which can be exploited to
influence the stoichiometry of a protein complex (9).
Several-fold higher expression with individual
promoters compared to polycistronic transcription has
been reported (10). A recent evaluation of co-expression
experiments performed by the Structural Proteomics in
Europe (SPINE) consortium compared examples of
co-expression with various systems (11).
The pETDuet system of Novagen allows construction
of a co-expression plasmid for two genes in a single
PCR step. Alternative approaches to co-expression
from a single vector require different sets of restriction
enzymes for multiple insertions. Berger et al. have
developed a Baculovirus co-expression system that
allows iterative addition of genes to a Baculovirus
vector (12). Alexandrov et al. have developed a vector
with a ‘LINK’ sequence that allows fusion of two
plasmids into one (13). The method allows cloning of
all cDNAs of interest into one standard expression vector
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by a standardized, high-throughput procedure. Then,
co-expression plasmids are generated by fusion of LINK
sequences with the ligation-independent cloning method
(LIC) that avoids PCR, which may introduce mutations.
Two alternative rare cutting restriction enzymes are used.
Inserts to be cloned are unlikely to contain both sites.
The method is limited to co-expression of two proteins.
We have designed a modified version of the LINK
sequence cloning technique. Vectors with two modified
LINK sequences were created that allow the creation of
co-expression plasmids by the established LINK cloning
procedure but avoid the duplication of the vector back-
bone. In principle, the vectors can accept an unlimited
number of genes to be co-expressed.
To demonstrate the usefulness of the method,
co-expression and binding of VCP and the C-terminus
of AMFR (14,15) is demonstrated. In addition, the
co-expression of four subunits of the human transport
protein particle (TRAPP) (16) from a single plasmid and
an analysis of their stoichiometry is shown.
MATERIALS AND METHODS
Vector construction
The vector pQTEV2 was constructed from pQE-2
(Qiagen) by replacing the multiple cloning site with
synthetic oligonucleotides to introduce a TEV protease
site and attB Gateway recombination sites. To obtain
pQLinkH, LINK sequences were inserted by PCR
amplification of bp 2–379 of pQTEV2 with the primers
50-TTTCTCGAGC TTAATTAACA ACACCATTTG
TCGAGAAATC ATAAAAAATT TATT-30 and
50-TTTTGCTAGC CTTAATTAAC CACTCCATTT
GTAACCACTC CATTTAAATG GTGTTGTTAC
TTGGATTCTC ACCAATAAAA A-30 and cloning of
the product into pQTEV2 using XhoI and NheI.
To construct pQLinkG, a GST coding sequence was
PCR amplified from pGEX-5X-1 (GE Healthcare) with
primers carrying EcoRI and PstI restriction sites.
The fragment was cloned between the EcoRI and PstI
sites of pQLinkH, thereby removing the His-tag.
pQLinkHD and pQLinkGD were obtained from
pQLinkH and pQLinkG—which contain attB sites—by
Gateway BP reactions with pDONR221, which inserted
the Gateway destination vector cassettes. pQLinkHD and
pQLinkGD confer both ampicillin and chloramphenicol
resistance and require the strain DB31 for propagation.
The vector pQLinkN without a tag was generated from
pQLinkH using QuikChangeTM site-directed mutagenesis
(17) with the double-stranded oligonucleotide
50-AAAGAGGAGA AATTAACTAT GGGATCCAGT
CTTCGCATGC AT-30. The sequences of the new vectors
were verified by sequencing and were submitted to
GenBank (EF025686–EF025689, EF196676).
Cloning of expression clones
The E. coli strain SCS1 with the helper plasmid pRARE
for over-expression of rare tRNAs (18) was used as
a host for cloning of expression and co-expression clones,
unless indicated otherwise. The VCP coding sequence
(GenBank NP_009057) was cloned into pQLinkH and
AMFR C-terminal regions (GenBank NP_001135) and
into pQLinkG (AMFR) with BamHI and NotI. BamHI/
NotI fragments of full-length cDNAs encoding four
human TRAPP subunits were cloned into pQLinkH.
The Bet3 (GenBank AF041432) and Mum2 (AAD44697)
full-length cDNAs lack the native start and stop codons
and were cloned with the BamHI site adjacent to the
second codon and with a stop codon downstream of the
NotI site, which encodes for three additional C-terminal
alanine residues. Full-length Tpc6 (CAD61947) and
synbindin (AAH10866) cDNAs were cloned with the
BamHI site adjacent to the native start codon and with
a TGA stop codon replacing the native stop codon. The
Bet3:Tpc6 pETDuet-1 clone was described previously (2).
Cloning of co-expression clones
Co-expression plasmids were cloned according to
Alexandrov et al. (13). To produce a co-expression
plasmid from two pQLink plasmids, 0.2–0.5 mg of one
plasmid was digested overnight with 5 units PacI in 10 ml
at 378C while the other was cleaved with 5 units SwaI at
258C. GST-plasmids were digested with PacI because the
GST coding region contains a SwaI site. Enzymes were
inactivated at 658C for 20min and 5 ml DNA was treated
with 1.3 units LIC qualified T4 DNA polymerase (Merck
Biosciences) in 20 ml (50mM Tris-HCl, pH 8.0, 10mM
MgCl2, 5 mg/ml BSA, 5mM DTT, 2.5mM dCTP for the
PacI digest and 2.5mM dGTP for the SwaI digest). Upon
incubation for 30min at 258C and heat inactivation at
658C for 20min, the two plasmids were mixed and heated
to 658C and cooled to room temperature for annealing.
Two microlitres of 25mM EDTA were added, followed by
E. coli transformation. Transformants were tested for
expected inserts by colony PCR with primers pQTEV3U,
50-TATAAAAATA GGCGTATCAC GAGG-30 and
pQTEV3L, 50-CCAGTGATTT TTTTCTCCAT TTT-30
and 598C annealing temperature. These primers are
positioned upstream of the LINK1 and downstream of
the LINK2 sequences, respectively.
Co-expression of AMFR and VCP and GST pull down
His-VCP:GST-AMFR co-expression plasmids were
expressed in 2 l with 1mM IPTG for 4 h at 168C. Cells
were harvested, resuspended in 20mM Tris-HCl, pH 7.5,
150mM NaCl, 2mM b-mercaptoethanol, 1mM PMSF
and 1 tablet/50ml lysate of Roche complete EDTA-free
protease inhibitor cocktail and lysed via incubation
with 0.5mg/ml lysozyme for 30min on ice, followed by
addition of 8 units/ml benzonase and treatment with an
Avestin Emulsiflex C5 homogenizer. Insoluble material
was removed by centrifugation (30min, 75 000 g) and the
lysate was loaded on a glutathione sepharose column. The
column was washed with wash buffer (20mM Tris-HCl,
pH 7.5, 150mM NaCl) and incubated overnight with
0.1mg/ml TEV protease in wash buffer at 88C. Proteins
mobilized by the protease were collected and analysed by
SDS-PAGE.
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Co-expression and pull down with nickel chelating beads
Protein expression and purification were performed as
described (19). Briefly, proteins were expressed in 1ml
cultures with 1mM IPTG at 378C (TRAPP proteins) or
168C (AMFR and VCP). His-tag fusion proteins and their
bound interaction partners were immobilized on Ni-NTA
agarose (Qiagen), washed with 20mM Tris-HCl, pH 8.0,
300mM NaCl and 20mM imidazole and then eluted with
70 ml 500mM imidazole in wash buffer. Six-microlitre
aliquots of eluate were analysed by SDS-PAGE.
BL21 (DE3) E. coli clones with pETDuet-1 Bet3:Tpc6
(2) and pQLinkH Bet3:pQLinkN Tpc6 plasmids were
cultured in 50ml and protein expression was induced with
1mM IPTG at OD600 0.7 for 4 h.
Purification and characterization of TRAPP subcomplexes
TRAPP co-expression plasmids were expressed in 0.5 l
overnight expressTM instant TB medium (Novagen). Cells
were lysed using a French Press (SLM-AMINCO) and
purified using Ni-NTA agarose (Qiagen), according to the
manufacturer’s instructions. Gel filtration was performed
on a Superdex 200 26/60 column (GE Healthcare)
equilibrated with 20mM Tris-HCl pH 7.5, 200mM
NaCl and 2mM DTT.
RESULTS
Vector construction
We have constructed five vectors for protein expression
in E. coli that allow preparation of co-expression
constructs by a simple cloning procedure (Figure 1). The
vectors contain two LINK sequences (13) that flank the
expression cassette of promoter, multiple cloning site
and a transcriptional terminator. LINK1 contains a
PacI restriction site and LINK2 a SwaI and a PacI site
(Figure 1A). The LINK sequences allow insertion of a
PacI fragment of one plasmid at the SwaI site of another
plasmid by LIC (Figure 1B).
The vectors pQLinkH and pQLinkG have a His-tag and
a GST-tag, respectively, followed by a TEV protease site
and a multiple cloning site. The vector pQLinkN is used
for expression of proteins without a tag. It contains a start
codon adjacent to the BamHI site and can be used to
express a protein complex with only one tagged subunit
for isolation. In the vectors pQLinkHD and pQLinkGD,
the TEV site and the multiple cloning site of pQLinkH
and pQLinkG were replaced by a cassette for Gateway
recombination cloning. The vectors pQLinkH and
pQLinkG contain Gateway attB sites and inserts can be
shuttled by a reverse Gateway reaction into a pDONR
donor vector to obtain Entry clones. Vector sequences
were submitted to GenBank (EF025686–EF025689,
EF196676) and vectors will be available from Addgene.
The cloning of co-expression plasmids by LIC was very
robust in our hands and about 90% of transformants
contained the expected insert. Correct clones are easily
recognized by the large product size of colony PCRs.
Co-expression of VCP and AMFR
The GST coding sequence contains a SwaI site, which
requires that pQLinkG clones are cut with PacI and not
with SwaI when generating a co-expression clone. To
circumvent this limitation, pQLinkG2 was generated by
introducing a silent mutation that removes this site in
pQLinkG. To study the interaction of VCP and AMFR, a
human VCP cDNA was cloned into pQLinkH and three
C-terminal fragments of the 643 amino acid coding region
of AMFR were cloned into pQLinkG. These fragments
comprise the Cue domain (amino acids 450–510), the
downstream region up to the C-terminus (498–643) and
a combination of both (455–643). Previously, the larger
constructs were found to interact with VCP, but not
with amino acids 450–510 (15). His-VCP:GST-AMFR
co-expression clones were obtained by inserting a PacI
fragment of the VCP plasmid into the LINK2 sequence of
the AMFR pQLinkG plasmids. Protein expression was
induced and the expression products of two His-
VCP:GST-AMFR co-expression clones were coupled to
a glutathione agarose column. The column was treated
with TEV protease to separate AMFR and GST and elute
AMFR and any attached proteins. Co-expression was
successful and, as shown in Figure 2A, the longer AMFR
fragment bound to His-VCP while the shorter one did not.
Reverse pull-down experiments were also performed
by coupling His-VCP to nickel chelating beads.
Co-purification with this matrix was generally less efficient
than with glutathione agarose. Co-purified bands were
observed upon Coomassie staining and anti-GST western
blotting for the AMFR constructs 456–643 and 498–643
(Figure 4B). Only a weak background of co-purified
GST and of the small AMFR construct was observed.
These results indicate that amino acids 498–643 of
AMFR, the region downstream of the Cue domain, are
responsible for the interaction with VCP, as it was found
by Grelle et al. (15).
Purification and characterization of TRAPP subcomplexes
Upon construction of a co-expression plasmid, only
the outer LINK sequences reconstitute (Figure 1B).
Therefore, it is possible to continuously increase the
number of genes by combining plasmids that carry
any number of expression cassettes. We have constructed
a co-expression plasmid for four subunits of the human
TRAPP complex. Bet3, Tpc6, Mum2 and synbindin were
cloned into pQLinkH, and the expression of individual
proteins was tested by small-scale expression and metal
chelate affinity chromatography (Figure 3A). A Bet3
and Tpc6 co-expression plasmid was constructed and
a several-fold increase in the yield of purified Tpc6 was
achieved (Figure 3A). This result is in agreement with
earlier studies that showed that the Bet3:Tpc6 heterodimer
is likely to represent the physiologically relevant form
of both proteins (2). Mum2 was included in the plasmid,
and finally a plasmid with all four subunits, including
synbindin, was constructed. The yield of purified Mum2
was also increased upon co-expression. All four subunits
of the complex were successfully co-expressed and the
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Figure 1. Map of the pQLink vectors and construction of co-expression plasmids. (A) Map of vector pQLinkH and genetic elements of all pQLink
vectors. The LINK sequences are shown with lines indicating overhangs generated by restriction digest and T4 DNA polymerase treatment.
MCS¼multiple cloning site, TEV¼TEV protease cleavage site, term.¼ transcription terminator. (B) Construction of a co-expression plasmid from
two pQLink plasmids with two different cDNA inserts, labelled 1 and 2. The resulting plasmid can accept additional inserts, labelled 3 and 4.
S¼SwaI, P¼PacI. (C) The LINK sequences and their digestion and annealing. The lines indicate overhangs generated by restriction digest and T4
DNA polymerase treatment. Two plasmids, identified by upper and lower case nucleotide codes, are digested and annealed, leading to a product with
a LINK1 and a LINK20 sequence, slightly larger than the original LINK2 sequence.
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yield of purified protein was equal to or better than that
for the expression of the individual proteins.
We compared the expression achieved by our system
to the pETDuet co-expression system. The plasmids
pETDuet-1 Bet3:Tpc6 and pQLinkH Bet3:pQLinkN
Tpc6 both encode for His-tagged Bet3 and untagged
Tpc6 protein. The expression clones showed good expres-
sion of both proteins, with comparable protein levels
in both systems (Figure 3B). Bet3 from pQLinkH was
more strongly expressed and migrated at a higher
molecular weight because of the TEV cleavage site not
present in pETDuet-1.
With expression constructs containing up to four
subunits in hand, we used the pQLink system to study
the assembly and stoichiometry of TRAPP subcomplexes.
Combinations of Bet3:Tpc6, Bet3:Tpc6:Mum2 and
Bet3:Tpc6:Mum2:synbindin were expressed and affinity
purified using nickel chelating beads. Samples were then
analysed by gel filtration to isolate the protein subcom-
plexes (Figure 4A). As previously described, Bet3 and
Tpc6 form a heterodimer, which binds Mum2 (2).
The isolated Bet3:Tpc6:Mum2 complex exhibited a
molecular weight of 90 kDa. A heterotrimer would
have a molecular weight of only 65 kDa, which suggests
that the observed complex contains a fourth TRAPP
polypeptide. It might result from binding of a Mum2
dimer to a Bet3:Tpc6 heterodimer, since Mum2 alone
forms homodimers (unpublished observation). Upon
including synbindin in the co-expression system,
a complex of similar size was formed, corresponding to
a 85-kDa tetramer containing one molecule each of Bet3,
Tpc6, Mum2 and synbindin. This tetrameric complex
could be isolated and crystallized (not shown).
DISCUSSION
The vectors described here allow generation of expression
clones for His-tag and GST-tag fusion proteins and
untagged proteins by restriction enzyme or Gateway
recombination-based methods. The vectors are capable
of expressing single proteins and can be converted into
co-expression plasmids by a simple, PCR-free LIC
reaction that is suitable for high-throughput projects.
Any combination of pQLink plasmids is possible.
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Figure 2. Co-expression of His-tagged VCP with GST-tagged AMFR fragments. SDS-PAGE and Coomassie staining of whole cells solubilized in
SDS-PAGE sample buffer (W) and proteins purified under non-denaturating conditions (P) (A) Proteins were eluted from a glutathione agarose
column by TEV protease treatment and analysed by SDS-PAGE and Coomassie staining. Degradation products of the larger AMFR construct were
observed. W¼whole cellular protein extract, P¼ purified proteins, M¼molecular weight marker. (B) Protein products of co-expression clones of
His-VCP with GST-AMFR and GST alone were purified with nickel chelating beads and separated by SDS-PAGE and visualized by Coomassie
staining (upper panel) or anti-GST western blot (lower panel, reagents: anti-GST HRP conjugate, GE-Healthcare, and Western Lightning Western
Blot Chemiluminescence Reagent, Perkin Elmer).
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The use of different tags or the combination of tagged and
untagged complex subunits facilitates the production of
homogenous complex preparations.
The presence of an internal SwaI or PacI site in the gene
of interest would prevent the use of the system. However,
SwaI and PacI are rarely cutting enzymes with eight
base pair recognition sites, and one is free to choose either
PacI or SwaI for a given gene. Therefore we expect
that almost all genes of interest can be converted into
co-expression clones. The comparison of yields showed
that this expression system works equally well as the
pETDuet system.
The specific interaction of a C-terminal region of
AMFR with VCP was confirmed. Co-expression of the
four TRAPP subunits Bet3, Tpc6, Mum2 and synbindin
was demonstrated. Figure 3 shows that co-expression
generally does not decrease the yield of individual
proteins. On the contrary, all four proteins were obtained
with similar or increased yield upon co-expression and
affinity purification. Gel filtration revealed that the four
TRAPP subunits form a heterotetramer containing one
molecule of each of the four TRAPP subunits. Bet3, Tpc6
and Mum2 without synbindin form a complex of similar
size, which suggests that this complex is also a tetramer
that might include two Mum2 molecules. These findings
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Figure 3. Co-expression of four subunits of the human TRAPP
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analysed by SDS-PAGE and Coomassie staining. W¼whole cellular
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agree with a recent study that identified TRAPP
subcomplexes consisting of Bet3:Tpc6:Mum2 and
Mum2:synbindin, respectively (20).
In addition to the co-expressions documented here,
we generated co-expression constructs for 20 other pairs
of human proteins using the Gateway pQLink vectors.
Cloning was robust and expression levels of individual
and co-expressed proteins were similar in virtually all
cases (data not shown). This further demonstrates the
robustness of our method.
In principle, there is no limit to the number of proteins
that can be co-expressed, even though one should
expect that the cloning efficiency decreases as the size
of the plasmid constructs increases. It seems likely
that our method can be transferred to expression
host systems other than E. coli. For Baculovirus vectors,
a co-expression system that also relies on duplication of
expression cassettes including promoters and transcription
terminators has been described (12). This demonstrates
that duplication of promoters and terminators in a
Baculovirus vector is unproblematic as has been shown
by Alexandrov et al. and in our work with E. coli vectors.
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